Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Engel

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Bioorganic Chemistry|March 10, 2021
Synthesis, biological evaluation and molecular docking studies of indeno [1, 2-c] pyrazol derivatives as inhibitors of mitochondrial malate dehydrogenase 2 (MDH2)Farzaneh Ahmadi, Matthias Engel, Mehdi M Baradarani
Archiv Der Pharmazie|July 19, 2023
Targeting the binding pocket of the fluorophore 8-anilinonaphthalene-1-sulfonic acid in the bacterial enzyme MurAReem K Fathalla, Matthias Engel, Christian Ducho
European Journal of Medicinal Chemistry|February 21, 2016
Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2Marica Mariano, Rolf W Hartmann, Matthias Engel
Medchemcomm|August 16, 2018
Design and synthesis of conformationally constraint Dyrk1A inhibitors by creating an intramolecular H-bond involving a benzothiazole coreMohamed Salah, Mohammad Abdel-Halim, Matthias Engel
The Journal of Biological Chemistry|June 8, 2004
Phosphoglycerate mutase-derived polypeptide inhibits glycolytic flux and induces cell growth arrest in tumor cell linesMatthias Engel, Sybille Mazurek, Erich Eigenbrodt, et al.
Medchemcomm|August 16, 2018
Design and synthesis of novel 1,3,5-triphenyl pyrazolines as potential anti-inflammatory agents through allosteric inhibition of protein kinase Czeta (PKCζ)Mohammad Abdel-Halim, Ashraf H Abadi, Matthias Engel
Analytical and Bioanalytical Chemistry|March 13, 2014
Screening Dyrk1A inhibitors by MALDI-QqQ mass spectrometry: systematic comparison to established radiometric, luminescence, and LC-UV-MS assaysDavid Gode, Christian Schmitt, Matthias Engel, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Hydroxybenzothiophene Ketones Are Efficient Pre-mRNA Splicing Modulators Due to Dual Inhibition of Dyrk1A and Clk1/4Christian Schmitt, Parisa Miralinaghi, Marica Mariano, et al.
Journal of Medicinal Chemistry|June 1, 2017
Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant ProteinsAhmed K ElHady, Mohammad Abdel-Halim, Ashraf H Abadi, et al.
Chemmedchem|July 22, 2014
6-Hydroxybenzothiophene ketones: potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) owing to favorable molecule geometry and conformational preorganizationParisa Miralinaghi, Christian Schmitt, Rolf W Hartmann, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Bioorganic Chemistry|March 10, 2021
Synthesis, biological evaluation and molecular docking studies of indeno [1, 2-c] pyrazol derivatives as inhibitors of mitochondrial malate dehydrogenase 2 (MDH2)Farzaneh Ahmadi, Matthias Engel, Mehdi M Baradarani
Archiv Der Pharmazie|July 19, 2023
Targeting the binding pocket of the fluorophore 8-anilinonaphthalene-1-sulfonic acid in the bacterial enzyme MurAReem K Fathalla, Matthias Engel, Christian Ducho
European Journal of Medicinal Chemistry|February 21, 2016
Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2Marica Mariano, Rolf W Hartmann, Matthias Engel
Medchemcomm|August 16, 2018
Design and synthesis of conformationally constraint Dyrk1A inhibitors by creating an intramolecular H-bond involving a benzothiazole coreMohamed Salah, Mohammad Abdel-Halim, Matthias Engel
The Journal of Biological Chemistry|June 8, 2004
Phosphoglycerate mutase-derived polypeptide inhibits glycolytic flux and induces cell growth arrest in tumor cell linesMatthias Engel, Sybille Mazurek, Erich Eigenbrodt, et al.
Medchemcomm|August 16, 2018
Design and synthesis of novel 1,3,5-triphenyl pyrazolines as potential anti-inflammatory agents through allosteric inhibition of protein kinase Czeta (PKCζ)Mohammad Abdel-Halim, Ashraf H Abadi, Matthias Engel
Analytical and Bioanalytical Chemistry|March 13, 2014
Screening Dyrk1A inhibitors by MALDI-QqQ mass spectrometry: systematic comparison to established radiometric, luminescence, and LC-UV-MS assaysDavid Gode, Christian Schmitt, Matthias Engel, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Hydroxybenzothiophene Ketones Are Efficient Pre-mRNA Splicing Modulators Due to Dual Inhibition of Dyrk1A and Clk1/4Christian Schmitt, Parisa Miralinaghi, Marica Mariano, et al.
Journal of Medicinal Chemistry|June 1, 2017
Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant ProteinsAhmed K ElHady, Mohammad Abdel-Halim, Ashraf H Abadi, et al.
Chemmedchem|July 22, 2014
6-Hydroxybenzothiophene ketones: potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) owing to favorable molecule geometry and conformational preorganizationParisa Miralinaghi, Christian Schmitt, Rolf W Hartmann, et al.
Pageof 8